CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar ipfmanager (93.66) Submitted: 3/25/2009 9:50:02 PM : Outperform Start Price: $5.71 CRY Score: -81.55

bio glue.

Featured Broker Partners


Advertisement